Literature DB >> 26220700

Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.

Sandra Janssens1, Davit Chokoshvilli1,2, Carmen Binst3, Inge Mahieu3, Lidewij Henneman4, Anne De Paepe1, Pascal Borry2.   

Abstract

Cystic fibrosis (CF) is a life-limiting autosomal recessive disorder affecting ~1 in 2500-4000 Caucasians. As most CF patients have no family history of the disorder, carrier screening for CF has the potential to prospectively identify couples at risk of conceiving an affected child. At-risk couples may consequently choose to act on the provided information and take steps to avoid the birth of a child with CF. Although carrier screening is widely believed to enhance reproductive autonomy of prospective parents, the practice also raises important ethical questions. A written questionnaire was administered to adult patients and parents of children with CF with the aim to explore participants' attitudes toward CF carrier screening and related reproductive issues. The study population was recruited from a CF patient registry in Belgium and comprised 111 participants (64 parents, 47 patients aged 16 or older). We found that more than 80% of all participants were in favor of preconception carrier screening for CF. However, some were concerned over potential negative consequences of population-wide CF carrier screening. Regarding future reproductive intentions, 43% of the participants indicated a desire to have children. Among these, preimplantation genetic diagnosis was found to be the most preferred reproductive option, closely followed by spontaneous pregnancy and prenatal diagnosis. Although the findings of our study suggest that patients and parents of children with CF support a population-based carrier screening program for CF, they also highlight some issues deserving particular attention when implementing such a program.

Entities:  

Mesh:

Year:  2015        PMID: 26220700      PMCID: PMC4929879          DOI: 10.1038/ejhg.2015.160

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  38 in total

1.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening.

Authors:  Francis A M Poppelaars; Herman J Adèr; Martina C Cornel; Lidewij Henneman; Rosella P M G Hermens; Gerrit van der Wal; Leo P ten Kate
Journal:  J Genet Couns       Date:  2004-02       Impact factor: 2.537

3.  Current practice and attitudes of Australian obstetricians toward population-based carrier screening for inherited conditions.

Authors:  Zornitza Stark; John Massie; Belinda McClaren; Liane Ioannou; Nicole Cousens; Sharon Lewis; Sylvia Metcalfe; Martin B Delatycki
Journal:  Twin Res Hum Genet       Date:  2013-01-21       Impact factor: 1.587

4.  Disability rights, prenatal diagnosis and eugenics: a cross-cultural view.

Authors:  Aviad E Raz
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

5.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

6.  Carrier screening for cystic fibrosis: test acceptance and one year follow-up.

Authors:  J C Levenkron; S Loader; P T Rowley
Journal:  Am J Med Genet       Date:  1997-12-31

7.  Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).

Authors:  L Henneman; I Bramsen; T A Van Os; I E Reuling; H G Heyerman; J van der Laag; H M van der Ploeg; L P ten Kate
Journal:  Prenat Diagn       Date:  2001-01       Impact factor: 3.050

Review 8.  Cystic fibrosis and fertility.

Authors:  Asima Ahmad; Aysha Ahmed; Pasquale Patrizio
Journal:  Curr Opin Obstet Gynecol       Date:  2013-06       Impact factor: 1.927

Review 9.  Population genetic screening programmes: principles, techniques, practices, and policies.

Authors:  Béatrice Godard; Leo ten Kate; Gerry Evers-Kiebooms; Ségolène Aymé
Journal:  Eur J Hum Genet       Date:  2003-12       Impact factor: 4.246

10.  Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem.

Authors:  Marieke J H Baars; Lidewij Henneman; Leo P Ten Kate
Journal:  Genet Med       Date:  2005 Nov-Dec       Impact factor: 8.822

View more
  11 in total

1.  Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium.

Authors:  Davit Chokoshvili; Carmen Belmans; Roxanne Poncelet; Sofie Sanders; Deborah Vaes; Danya Vears; Sandra Janssens; Isabelle Huys; Pascal Borry
Journal:  Genet Test Mol Biomarkers       Date:  2017-03

2.  Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population.

Authors:  Thirsa Conijn; Ivy van Dijke; Lotte Haverman; Phillis Lakeman; Frits A Wijburg; Lidewij Henneman
Journal:  J Community Genet       Date:  2021-03-22

3.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

4.  Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases.

Authors:  Mirjam Plantinga; Erwin Birnie; Kristin M Abbott; Richard J Sinke; Anneke M Lucassen; Juliette Schuurmans; Seyma Kaplan; Marian A Verkerk; Adelita V Ranchor; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

5.  Deciding on cystic fibrosis carrier screening: three citizens' juries and an online survey.

Authors:  Paola Mosconi; Cinzia Colombo; Anna Roberto; Giulia Candiani; Maria Teresa Greco; Roberto Satolli; Carlo Castellani
Journal:  Eur J Public Health       Date:  2018-10-01       Impact factor: 3.367

6.  Preventing lives affected by hemophilia: A mixed methods study of the views of adults with hemophilia and their families toward genetic screening.

Authors:  Felicity K Boardman; Rachel Hale; Raksha Gohel; Philip J Young
Journal:  Mol Genet Genomic Med       Date:  2019-03-05       Impact factor: 2.183

7.  How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening.

Authors:  Felicity K Boardman; Rachel Hale
Journal:  Mol Genet Genomic Med       Date:  2018-09-09       Impact factor: 2.183

8.  Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes.

Authors:  Thirsa Conijn; Stephanie C M Nijmeijer; Phillis Lakeman; Lidewij Henneman; Frits A Wijburg; Lotte Haverman
Journal:  J Genet Couns       Date:  2020-09-17       Impact factor: 2.537

9.  "I didn't take it too seriously because I'd just never heard of it": Experiential knowledge and genetic screening for thalassaemia in the UK.

Authors:  Felicity K Boardman; Rachel Hale
Journal:  J Genet Couns       Date:  2018-12-24       Impact factor: 2.537

10.  CF and male health: Sexual and reproductive health, hypogonadism, and fertility.

Authors:  Farah Naz Khan; Kelly Mason; Andrea H Roe; Vin Tangpricha
Journal:  J Clin Transl Endocrinol       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.